JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB218810

Anti-CD47 antibody [EPR21794]

  • RabMAb
  • Recombinant
  • KO Validated
  • 20ul selling size
  • What is this?

5

(1 Review)

|

(33 Publications)

Anti-CD47 antibody [EPR21794] (ab218810) is a rabbit monoclonal antibody detecting CD47 in Western Blot, IHC-P. Suitable for Human samples.

Enhanced IHC validation dataDownload the data
- detailed IHC expression profiling in normal and clinically relevant cancer FFPE TMAs - ovarian, lung, lymphoma
- protocols for BOND RX™ and Ventana DISCOVERY ULTRA
Cited in 2 publications
Biophysical QC for unrivalled batch-batch consistency

View Alternative Names

CD47, MER6, Leukocyte surface antigen CD47, Antigenic surface determinant protein OA3, Integrin-associated protein, Protein MER6, IAP

8 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD47 antibody [EPR21794] (AB218810)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD47 antibody [EPR21794] (AB218810)

Immunohistochemical analysis of formalin fixed paraffin embedded human non small cell lung carcinoma labelling CD47 with ab218810 at a concentration of 1µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.

ab218810 Anti-CD47 antibody [EPR21794] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD47 antibody [EPR21794] (AB218810)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD47 antibody [EPR21794] (AB218810)

Immunohistochemical analysis of formalin fixed paraffin embedded human ovarian carcinoma labelling CD47 with ab218810 at a concentration of 1µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.

ab218810 Anti-CD47 antibody [EPR21794] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD47 antibody [EPR21794] (AB218810)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD47 antibody [EPR21794] (AB218810)

Immunohistochemical analysis of formalin fixed paraffin embedded human placenta labelling CD47 with ab218810 at a concentration of 1µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.

ab218810 Anti-CD47 antibody [EPR21794] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD47 antibody [EPR21794] (AB218810)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD47 antibody [EPR21794] (AB218810)

Immunohistochemical analysis of paraffin-embedded human ovary carcinoma tissue labeling CD47 with ab218810 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Membranous and weakly cytoplasmic staining in human ovary carcinoma (PMID : 7998989). Counterstained with hematoxylin. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD47 antibody [EPR21794] (AB218810)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD47 antibody [EPR21794] (AB218810)

Immunohistochemical analysis of paraffin-embedded human liver tissue labeling CD47 with ab218810 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Membranous and weak cytoplasmic staining on sinus of human liver sinusoidal endothelial cells (PMID : 7998989). Counterstained with hematoxylin. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD47 antibody [EPR21794] (AB218810)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD47 antibody [EPR21794] (AB218810)

Immunohistochemical analysis of paraffin-embedded human placenta tissue labeling CD47 with ab218810 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Membranous staining on human placenta (PMID : 7998989). Counterstained with hematoxylin. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Western blot - Anti-CD47 antibody [EPR21794] (AB218810)
  • WB

Lab

Western blot - Anti-CD47 antibody [EPR21794] (AB218810)

Lanes 1-4 : Merged signal (red and green). Green - ab218810 observed at 47-52 kDa. Red - loading control ab8245 observed at 36 kDa.

ab218810 Anti-CD47 antibody [EPR21794] was shown to specifically react with CD47 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266324 (knockout cell lysate ab257220) was used. Wild-type and CD47 knockout samples were subjected to SDS-PAGE. ab218810 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-CD47 antibody [EPR21794] (ab218810) at 1/500 dilution

Lane 1:

Wild-type HEK293T cell lysate at 20 µg

Lane 2:

CD47 knockout HEK293T cell lysate at 20 µg

Lane 2:

Western blot - Human CD47 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-cd47-knockout-hek-293t-cell-line-ab266324'>ab266324</a>)

Lane 3:

Jurkat cell lysate at 20 µg

Lane 4:

HepG2 cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution

Predicted band size: 35 kDa

Observed band size: 47-52 kDa

false

Western blot - Anti-CD47 antibody [EPR21794] (AB218810)
  • WB

Supplier Data

Western blot - Anti-CD47 antibody [EPR21794] (AB218810)

Exposure time : Lane 1 : 26 seconds; Lane 2 : 70 seconds; Lanes 3-4 : 3 minutes; Lane 5 : 3 seconds.

Blocking/Dilution buffer : 5% NFDM/TBST.

We recommend that samples are not boiled after adding loading buffer as this may cause protein aggregates. The molecular mass observed is consistent with the literature (PMID 12393467, PMID 11034562).

Lanes 1 - 4:

Western blot - Anti-CD47 antibody [EPR21794] (ab218810) at 1/5000 dilution

Lane 5:

Western blot - Anti-CD47 antibody [EPR21794] (ab218810) at 1/1000 dilution

Lane 1:

Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg

Lane 2:

U937 (human histiocytic lymphoma cell line) whole cell lysate at 20 µg

Lane 3:

A549 (human lung carcinoma cell line) whole cell lysate at 20 µg

Lane 4:

U-2 OS (human bone osteosarcoma epithelial cell line) whole cell lysate at 20 µg

Lane 5:

Human brain lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 35 kDa

Observed band size: 47-52 kDa

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR21794

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/2000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

Product details

What is this antibody validated in?
Anti-CD47 antibody [EPR21794] (ab218810) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human samples.

What is the molecular weight of CD47?
Anti-CD47 [EPR21794] (ab218810) specifically detects a band for CD47 (UniProt: Q08722) at a molecular weight of 35kDa.

Trusted by the scientific community
Anti-CD47 [EPR21794] (ab218810) was first used in a scientific publication in 2018 and has been cited over 10 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-CD47 antibody [EPR21794] (ab218810) has been confirmed by Western blot testing in CD47 Knockout HEK293T cell line, ab266324.

Other related products
We have a range of other formats of antibody clone [EPR21794] also available for your convenience: ab218810, Carrier free - ab233122, Alexa Fluor® 488 - ab311045, Alexa Fluor® 647 - ab311170, Alexa Fluor® 594 - ab311824, Alexa Fluor® 568 - ab313107, Alexa Fluor® 555 - ab313300, Alexa Fluor® 750 - ab321400

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD47 also referred to as integrin-associated protein carries a molecular weight of approximately 50 kDa. This protein is broadly expressed across various cell types notably on erythrocytes leukocytes and endothelial cells. Its transmembrane glycoprotein structure allows it to perform various cellular functions. CD47 interacts with specific ligands prominently SIRPα which are present on immune cells such as macrophages and dendritic cells. The engagement of CD47 with these ligands plays a major role in cellular signaling processes.
Biological function summary

CD47 functions as a "don't eat me" signal inhibiting phagocytosis by binding to SIRPα on macrophages. This protein is also important for cell adhesion and migration and can modulate interactions with integrins. While not a part of a large complex CD47 associates with various cytoskeletal and membrane proteins to maintain cellular architecture and transmission of mechanical forces. Additionally its interaction with thrombospondins influences angiogenesis and nitric oxide signaling.

Pathways

CD47 is extensively involved in the regulation of the immune response and angiogenesis. The interaction between CD47 and SIRPα plays a part in the regulation of macrophage activity impacting the immune signaling pathway. CD47 also interacts with integrins allowing it to contribute to the angiogenesis pathway which is critical in the formation of new blood vessels. These interactions help coordinate complex cellular responses and maintain tissue homeostasis.

CD47 levels have associations with cancer and chronic inflammatory diseases. In cancer CD47 overexpression can allow tumor cells to evade the immune response by downregulating phagocytosis through SIRPα interaction. Therapeutically targeting CD47 using agents like anti-CD47 antibodies shows potential for enhancing anti-tumor immunity. Additionally CD47 is involved in atherosclerosis where its interaction with thrombospondin-1 contributes to disease pathogenesis by affecting nitric oxide signaling and vascular remodeling.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Adhesive protein that mediates cell-to-cell interactions (PubMed : 11509594, PubMed : 15383453). Acts as a receptor for thrombospondin THBS1 and as modulator of integrin signaling through the activation of heterotrimeric G proteins (PubMed : 19004835, PubMed : 7691831, PubMed : 8550562). Involved in signal transduction, cardiovascular homeostasis, inflammation, apoptosis, angiogenesis, cellular self-renewal, and immunoregulation (PubMed : 11509594, PubMed : 15383453, PubMed : 19004835, PubMed : 27742621, PubMed : 32679764, PubMed : 7691831, PubMed : 8550562). Plays a role in modulating pulmonary endothelin EDN1 signaling (PubMed : 27742621). Modulates nitrous oxide (NO) signaling, in response to THBS1, hence playing a role as a pressor agent, supporting blood pressure (By similarity). Plays an important role in memory formation and synaptic plasticity in the hippocampus (By similarity). Receptor for SIRPA, binding to which prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells (PubMed : 11509594). Interaction with SIRPG mediates cell-cell adhesion, enhances superantigen-dependent T-cell-mediated proliferation and costimulates T-cell activation (PubMed : 15383453). Positively modulates FAS-dependent apoptosis in T-cells, perhaps by enhancing FAS clustering (By similarity). Plays a role in suppressing angiogenesis and may be involved in metabolic dysregulation during normal aging (PubMed : 32679764). In response to THBS1, negatively modulates wound healing (By similarity). Inhibits stem cell self-renewal, in response to THBS1, probably by regulation of the stem cell transcription factors POU5F1/OCT4, SOX2, MYC/c-Myc and KLF4 (By similarity). May play a role in membrane transport and/or integrin dependent signal transduction (PubMed : 7691831). May prevent premature elimination of red blood cells (By similarity).
See full target information CD47

Publications (33)

Recent publications for all applications. Explore the full list and refine your search

Esophagus : official journal of the Japan Esophageal Society : PubMed40926176

2025

Expression of cluster of differentiation 47 (CD47) and signal regulatory protein alpha (SIRPα) as prognostic biomarkers and potentially therapeutic targets in esophageal squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Junpeng Li,Yohei Ozawa,Takeru Mozumi,Kaiyuan Jiang,Yusuke Taniyama,Chiaki Sato,Hiroshi Okamoto,Hirotaka Ishida,Naoto Ujiie,Shinobu Ohnuma,Michiaki Unno,Takashi Kamei

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e04200 PubMed40548645

2025

SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1-Mediated Transactivation of CD47.

Applications

Unspecified application

Species

Unspecified reactive species

Zhengfang Liu,Xiumei Zhao,Maolin Zang,Huiyang Yuan,Xin Qin,Xiaofeng Li,Shuo Zhao,Ruirong Tan,Keqiang Yan,Li Liu,Yidong Fan,Ning Zhang,Benkang Shi,Bo Han,Shouzhen Chen

Haematologica 110:2198-2202 PubMed40109184

2025

Dissecting CD47 expression in lymphoid neoplasms to inform precision immunotherapy with anti-CD47 phagocytic checkpoint blockade.

Applications

Unspecified application

Species

Unspecified reactive species

Andrea Marra,Alan Ramsay,Samuel Chamberlain-Keene,Gabriela Soares,Maurilio Ponzoni,Sugerdana Padmasri,Manuel Rodriguez-Justo,Sabine Pomplun,Ian Proctor,Anna Childerhouse,Alsharabati Muntasser,Mario Cioce,Vito Michele Fazio,German Ott,Miguel Piris,Brunangelo Falini,Teresa Marafioti

Annals of surgical treatment and research 108:98-106 PubMed39944922

2025

Exploring the prognostic role of cluster of differentiation 47 in patients with advanced pancreatic cancer: a comparative cohort study.

Applications

Unspecified application

Species

Unspecified reactive species

Eden Demere Amare,Sumi Lee,Dongho Choi,Ji Hyun Shin,Kyeong Geun Lee,Kyeong Sik Kim,Hyunsung Kim,Yun Kyung Jung

Frontiers in immunology 15:1426975 PubMed39399501

2024

Dysregulated C1q and CD47 in the aging monkey brain: association with myelin damage, microglia reactivity, and cognitive decline.

Applications

Unspecified application

Species

Unspecified reactive species

Sarah A DeVries,Christina Dimovasili,Maria Medalla,Tara L Moore,Douglas L Rosene

Human vaccines & immunotherapeutics 20:2408088 PubMed39348228

2024

A novel anti-CD47 antibody with therapeutic potential for NK/T-cell lymphoma.

Applications

Unspecified application

Species

Unspecified reactive species

Liping Qin,Yajun Li,Ruolan Zeng,Yizi He,Xiaoyan Chen,Ling Xiao,Hui Zhou

Biomedicines 12: PubMed39335665

2024

Targeting CD47 and Angiogenesis Demonstrates Effective Anti-Tumor Effect in Bladder Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Xiting Huang,Qian Wang,Yanyang Nan,Xuyao Zhang,Ke Xu,Dianwen Ju,Weihong Ding

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2402805 PubMed39119832

2024

Irisin-Encapsulated Mitochondria-Targeted Biomimetic Nanotherapeutics for Alleviating Acute Kidney Injury.

Applications

Unspecified application

Species

Unspecified reactive species

Xia Zhang,Lijia Liang,Fengxian Wang,Pedro A Jose,Ken Chen,Chunyu Zeng

Cancer immunology, immunotherapy : CII 73:75 PubMed38532108

2024

Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Kaiqi Zhang,Yuan Xu,Xusheng Chang,Caili Xu,Wenjing Xue,Dan Ding,Mingming Nie,Hui Cai,Jun Xu,Lu Zhan,Jiangbo Han,Tiancai Cai,Dianwen Ju,Li Feng,Xuyao Zhang,Kai Yin

Journal of endocrinological investigation 47:1953-1969 PubMed38386265

2024

Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer.

Applications

Unspecified application

Species

Unspecified reactive species

G-Q Zhang,C Xi,N-T Ju,C-T Shen,Z-L Qiu,H-J Song,Q-Y Luo
View all publications
enhancedValidationDataWebsite
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com